breast cancer - adjuvant | breast cancer - HR positive | |||
breast cancer - adjuvant | la/mBC - HR positive | la/mBC - HR-positive - 1st line (L1) | la/mBC - HR-positive - 2nd line (L2) | |
palbociclib based treatment | ||||
palbociclib | ||||
palbociclib plus endocrine therapy | PENELOPE-B | PENELOPE-B | ||
palbociclib plus fulvestrant | PALOMA-3 FLIPPER | |||
palbociclib plus letrozole |